News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Alliances
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014
Portola Pharmaceuticals, Inc. Announces Commercial Supply Agreement For Andexanet Alfa With Lonza Inc. 10/17/2014
Novadaq Corp. Appoints Kirloskar Technologies As Its Exclusive Distributor In India 10/17/2014
Osiris Therapeutics, Inc. (OSIR) And Arthrex, Inc. Announce An Exclusive Partnership For The Commercialization And Development Of Cartiform® 10/17/2014
Sihuan Pharmaceutical Announces Second Anti-Virus Partnership With AMMS 10/17/2014
Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc. (JNJ) 10/16/2014
AstraZeneca PLC (AZN) Strengthens Partnership With The University of Cambridge 10/16/2014
Sanofi Pasteur (SASY.PA) And Immune Design Corporation (IMDZ) Enter Broad Collaboration For The Development Of A Herpes Simplex Virus Therapy 10/16/2014
Nuvilex (NVLX) Secures Worldwide License For Insulin-Producing Cells From University of Technology Sydney, For Use In Developing Diabetes Treatment 10/16/2014
Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™ 10/16/2014
Cardiorentis AG And Roche (RHHBY) Announce Collaboration To Establish Therapeutic Impact Of Ularitide 10/16/2014
Batu Biologics Awarded Exclusive License From University of California, San Diego (UCSD) for Drug That Stimulates Immune System To Kill Cancer 10/16/2014
DNAnexus, Inc. Powers Novel Genomic Collaborations Between Regeneron Genetics Center And Leading Healthcare Institutions 10/16/2014
Tocris Bioscience And The Structural Genomics Consortium Sign Agreement For the Worldwide Distribution Of Novel Epigenetic Chemical Probes 10/16/2014
Pharmacyclics, Inc. (PCYC) Enters Into Agreement With Roche (RHHBY) To Evaluate IMBRUVICA® And GAZYVA® In Lymphoma And Leukemia 10/16/2014
Orexigen Therapeutics, Inc. (OREX) Pockets $100 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 10/15/2014
Boehringer Ingelheim Corporation And Americares Partner To Expand Product Donations Program Globally 10/15/2014
Selecta Biosciences, Inc., Juvenile Diabetes Research Foundation And Sanofi (SAN.PA) Extend Collaboration To Develop A Synthetic Vaccine Particle Immunotherapy For Type 1 Diabetes 10/15/2014
Discovery Laboratories (DSCO) Announces Strategic Collaboration With Battelle For AEROSURF® Program 10/15/2014
Bioheart, Inc. Announces Partnership In Colombia 10/15/2014
Deinove Teams Up With MBI, Pioneer Of Afex Technology, To Evaluate Its Process On Industrial Biomass 10/15/2014
Nanion Technologies And Axion Biosystems Announce Strategic Distribution Partnership In Europe And China 10/15/2014
NeuroSigma, Inc. And The U.S. Veterans Administration (VA) Enter Into Cooperative Research And Development Agreement (CRADA) 10/15/2014
Auspherix And Domainex Announce Collaboration To Develop New Drugs To Treat Antibiotic-Resistant Bacterial Infections 10/15/2014
Embattled Wilex AG (WL6.DE) Sells Unnamed Tumor Drug To Roche (RHHBY) For $65.8M 10/14/2014
Retrophin (RTRX) Announces Divestment Of Non-Core Assets To Turing Pharmaceuticals 10/14/2014
Advanced Biological Laboratories SA (ABL), University of Hong Kong, And The Hong Kong Polytechnic University Decide To Join Forces To Develop A Deep-Sequencing Tuberculosis Solution 10/14/2014
INC Research, Inc. Signs Agreement To Perform FDA Due Diligence Audit Of Regulatory Documents For Provectus Biopharmaceuticals Inc. 10/14/2014
Imaxio Signs An Option For A License Agreement With The German Cancer Research Center (DKFZ) 10/14/2014
BioSilta And Sigma-Aldrich Corporation (SIAL) Sign Global Distribution Agreement 10/14/2014
New Oncology And Gustave Roussy Announce Collaboration On Genetic Testing 10/14/2014
SELLAS Life Sciences Group Selects PPD, Inc. (PPDI) As Its Strategic CRO Partner To Advance Zolpidem And WT1 Cancer Vaccine 10/14/2014
The National Parkinson Foundation Partners With The International Parkinson And Movement Disorder Society To Deliver Health Professional Course 10/14/2014
Prophylix Pharma Signs Manufacturing Agreement With Emergent BioSolutions (EBS) 10/14/2014
Seahorse Bioscience And University of Alabama at Birmingham Partner To Advance Validation Of Bioenergetic Health Index For Personalized Medicine 10/14/2014
Exostar And BT Upgrade Relationship With New Alliance Agreement 10/14/2014
Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank 10/13/2014
Aratana Therapeutics (PETX) And Atopix Complete Global Licensing Agreement For Development And Commercialization Of Novel Atopic Dermatitis Program 10/13/2014
Biocept, Inc. (BIOC) And Rosetta Genomics Ltd. (ROSG) Collaborate To Evaluate Micrornas From Circulating Tumor Cells 10/13/2014
Rich Pharmaceuticals Announces Assignment Agreement Acquiring Complete Ownership, Development And Commercialization Rights For Indication, Patents And Intellectual Property Related To The Treatment Of Hodgkin's Lymphoma 10/13/2014
Veristat, Inc. And Molecular Templates Inc. Enter Into Preferred Provider Agreement For Refractory Non-Hodgkin’s B-Cell Lymphoma trial 10/13/2014
Sihuan Pharma Buys Rights To Ebola Drug From China's AMMS 10/13/2014
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014
Hikma Pharmaceuticals Enters Partnership With Eisai Company, Ltd. (ESALY.PK) For Distribution Of First-In-Class Epilepsy Treatment Fycompa® In Middle East 10/13/2014
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers 10/13/2014
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014
Pharming Group (PHGUF.PK) And Swedish Orphan Biovitrum Amend And Extend Ruconest Distribution Agreement 10/13/2014
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium 10/13/2014
MRC Technology And Proximagen Group plc. Collaborate To Develop Novel Therapeutics For Inflammatory And Autoimmune Disease 10/13/2014
Bacterial Robotics Announces Strategic Alliance With Bacmine SL And Formation Of Microbial Robotics 10/10/2014
AstraZeneca PLC (AZN) Completely Cuts Ties With Targacept, Inc. (TRGT) 10/10/2014
Oxford BioMedica PLC (OXB.L) Inks Transformational $90 Million Deal With Novartis AG (NVS) 10/10/2014
We've Secured Third Biosimilar License: Stada CEO 10/10/2014
Vernalis Licenses V2006 To Redoxtherapies Inc For Use In Immuno-Oncology 10/10/2014
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $18 Million From GlaxoSmithKline (GSK) 10/9/2014
Capricor Therapeutics, Inc. Announces Plans To Pursue A Cenderitide Clinical Program And Enters Into Research Support Agreement With Insulet Corporation (PODD) 10/9/2014
A*STAR’s Simtech Joins Hands With 8 Companies To Overcome Counting, Tracking And Supply Chain Woes 10/9/2014
International Medica Foundation Provides A Global Sublicense For The First Rotavirus Vaccine Intended For Newborns 10/9/2014
Immunotech Laboratories Enters Into Negotiations With Uldic Investment Pvt. Ltd. For Market Development 10/9/2014
ContraFect Corporation (CFRXU) And National Institute For Viral Disease Control And Prevention, China CDC Sign Agreement To Collaborate On Universal Influenza Treatment 10/9/2014
Procter & Gamble (PG) Release: Pepto-Bismol Partners With Six Flags To Bring Fright Fest® Guests More Thrills 10/9/2014
Tekmira (TKMR) Working Hand In Hand With WHO On Ebola Drug, Says CEO 10/8/2014
PharmaEngine, Inc. Will Join Nanobiotix' Pivotal Trial For NBTXR3 In Soft Tissue Sarcoma To Accelerate Its Development In Asia-Pacific 10/8/2014
Pfizer (PFE) And Breast Cancer Leaders Join Together To Increase Understanding And Dispel Myths About Metastatic Breast Cancer 10/8/2014
Cardio3 BioSciences Awarded Preferred Access Rights To Mayo Clinic Center For Regenerative Medicine Portfolio 10/8/2014
Dilafor Signs Supply And Partnership Agreement With OPOCRIN S.p.A 10/8/2014
Ubiquigent And University of Dundee Announce Collaboration To Develop Novel Ubiquitin System Targeted Compound Libraries 10/8/2014
BASF And Colorcon, Inc. Cooperate On Kollicoat® IR For Ready-To-Use Pharmaceutical Coating Solutions 10/8/2014
Med Fusion And GenomOncology Partner To Match Drug And Clinical Trial Options To Patient Tumors 10/8/2014
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014
Progenics Pharmaceuticals, Inc. (PGNX) Pockets A $40 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 10/7/2014
The Texas A&M University System And XOMA (US) LLC (XOMA) License Innovative Manufacturing Technology 10/7/2014
ICF International Wins $100 Million Blanket Purchase Agreement With National Institutes of Health (NIH) 10/7/2014
New England Biolabs, Inc. Announces Supply Agreement With TriLink BioTechnologies 10/7/2014
Second Genome And Mayo Clinic Enter Collaboration To Develop Microbiome Therapeutics In Multiple Diseases 10/7/2014
Arcadia Biosciences, Inc. And ArborGen To Develop Drought-Tolerant And Nitrogen-Efficient Eucalyptus Trees 10/7/2014
Charles River Laboratories (Massachusetts)’s Early Drug Discovery Collaboration With AstraZeneca PLC (AZN) Delivers Respiratory Candidate Drug 10/7/2014
Bukwang Pharm. Ind. Co., Ltd. Receives First Performance Milestone Payment From Bukwang Pharm. Ind. Co., Ltd. 10/7/2014
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014
The Reason Why Takeda Pharmaceutical Co. Ltd. (TKPYY) May Pay MacroGenics, Inc. (MGNX) Up To $1.6 Billion For Four Molecules That Don't Yet Exist 10/6/2014
Alliqua Biomedical (ALQA) Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics 10/6/2014
Unilife Corporation (UNIS), Sanofi (SAN.PA) Strike $50 Million Wearable Injectors Pact 10/6/2014
Immucor Announces NGS Collaboration With Sirona Genomics 10/6/2014
Collaboration With Dr. Stephen Waxman Of Yale University To Evaluate Pharmacology Of Nav1.7 Mutations In Chronic Pain Disorders 10/6/2014
Horizon Discovery Group Signs Co-Exclusive Commercial Agreement With Haplogen Genomics 10/6/2014
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014
West Pharmaceutical Services And HealthPrize Technologies Join Forces On Connected Health 10/6/2014
Society For Clinical Research Sites Welcomes New Global Impact Partner 10/6/2014
ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development 10/6/2014
Lockheed Martin Corporation And Yissum Ltd. Sign Long Term Research Collaboration Agreement 10/6/2014
Perosphere Inc. And Daiichi Sankyo, Inc. (4568.t) Enter Into A Clinical Trial Collaboration Agreement For Phase 3 Studies Of PER977 To Investigate Reversal Of The Anticoagulant Activity Of The Investigational Factor Xa-Inhibitor Edoxaban 10/6/2014
Pharmaceutical Services Provider Biosolutia Turns To 8x8 To Ensure Uptime, Security And Customer Engagement Success For Cloud Contact Center 10/6/2014
Islet Sciences Announces Exclusive Licensing Agreement Between BHV Pharma, Inc. And Libbs Farmaceutica To Develop And Commercialize SGLT2 Inhibitor Remogliflozin Etabonate 10/6/2014
India Brand Equity Foundation (IBEF), Release: Government Of India And Pharma Industry Jointly Form The India – Responsible Healthcare Trust 10/6/2014
Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact 10/6/2014
Stock Soars As Baxter International, Inc. (BAX) Bets $45M On Kidney Drugmaker Rockwell Medical (RMTI) 10/3/2014
A*STAR And Japan Science And Technology Agency Renews Research Cooperation 10/3/2014
D&A Pharma Signs Licensing And Distribution Agreement With Grupo JUSTE For ALCOVER® In Spain And Central America 10/3/2014
NeurOp Corporation Receives Milestone Payment As Bristol-Myers Squibb Company (BMY) Nominates NMDA Receptor Compound As Drug Development Candidate 10/3/2014
Sigma-Aldrich Corporation (SIAL) Agrees To Acquire Cell Marque To Strengthen Immunohistochemistry Business 10/3/2014
Tekmira Pharmaceuticals Corporation (TKMR) Achieves $1.5 Million Development Milestone 10/3/2014
AMPAC Fine Chemicals Partners With CHEMGO Organica AG Of Switzerland 10/3/2014
Histogenics Corporation And Intrexon Corporation Announce Formation Of Exclusive Channel Collaboration For Cartilage Repair Therapies 10/3/2014
NetScientific’s Subsidiary, Glycotest Begins A New Research Collaboration With Oncimmune LLC 10/3/2014
Incyte Corporation (INCY) Pockets $60 Million Milestone Payment From Novartis AG (NVS) 10/2/2014
Oxford BioTherapeutics And Berlin-Chemie/Menarini Group Progress Antibody-Drug Conjugate As Second Clinical Development Candidate In $1 Billion Oncology Investment Alliance 10/2/2014
VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center 10/2/2014
Intrexon Corporation And Amneal Pharmaceuticals Expand Relationship With Second Product Collaboration 10/2/2014
Cambridge Research Biochemicals Signs Licensing Deal With The Scripps Research Institute 10/2/2014
AB SCIEX And Illumina, Inc. (ILMN) Collaborate To Create World’s First Multi-omics Cloud-Computing Environment 10/2/2014
Vince & Associates Clinical Research Continues Collaboration With Cambridge Cognition Ltd For Electronic Visual Analog Scales For Human Abuse Liability Trials 10/2/2014
Novartis AG (NVS) Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal 10/1/2014
MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draw Up $1.6B DART Pact 10/1/2014
GE Corporation (GE), University of California, San Francisco (UCSF), Agencies Partner Up To Define, Attack Traumatic Brain Injuries 10/1/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $1.5 Million From GlaxoSmithKline (GSK) For The Advancement Of ISIS-GSK4 Rx 10/1/2014
Northwestern University Joins $20 Million National Uterine Fibroid Study 10/1/2014
Protein Metrics Licenses Lipid Analysis Software From Pacific Northwest National Laboratories 10/1/2014
Bitplane Brings Voloom To The Wider Life Sciences Market 10/1/2014
Dyadic International, Inc. Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 10/1/2014
Abaxis, Inc. (ABAX) Announces Distribution Agreement With Patterson Veterinary Supply 10/1/2014
Karmanos Cancer Institute, Wayne State University Enhance Commitment To Cancer Care, Research 10/1/2014
Open Monoclonal Technology, Inc. Grants Unlimited OmniRat, OmniMouse And OmniFlic License 10/1/2014
Clinical Conductor CTMS And OpenClinica EDC Form First Of Its Kind Partnership 10/1/2014
Swiss Foundation For People With Rare Diseases Combines GENALICE And Knome Solutions To Improve DNA Analysis 10/1/2014
MannKind Corporation (MNKD) Pockets $150 Million Upfront Payment From Sanofi (France) (SAN.PA) 9/30/2014
Pfizer (PFE), Kyowa Hakko Kirin Team Up On Immuno-Oncology Combination Study 9/30/2014
Evotec AG (EVTG.F) Receives Milestone As Part Of Its Multi-Target Alliance With Bayer HealthCare (BAY) 9/30/2014
Cannabis Science Inc. Signs Drug Development And Laboratory Services Agreement With Immunoclin Corporation (Imcl); Collaboration To Advance Clinical Studies And Formulations Of The Company's Proprietary Cannabinoid Based Products 9/30/2014
Novadaq Corp. Announces Multi-Unit Agreement With Serenagroup For LUNA 9/30/2014
BioLife Solutions, Inc. (BLFS.OB) Forms biologistex CCM(SM) Joint Venture With SAVSU® Technologies To Market Intelligent, Controlled Temperature Containers For Biologics 9/30/2014
Leidos Awarded $25 Million Task Order By Department Of Veterans Affairs 9/30/2014
Lead Discovery Center Enters First Collaboration With The Helmholtz Association 9/30/2014
Celerion Expands Ophthalmological Capabilities To Patient Populations In Collaboration With Queen’s University, Belfast. 9/30/2014
CORD:USE Is Pleased To Announce It Has Partnered With Tianhe Stem Cell Biotechnologies, Developer Of Cord Blood Stem Cell Therapy Showing Promising Results In Clinical Trials For The Treatment Of Diabetes And Autoimmune Diseases 9/30/2014
Jacobs Engineering Group Inc. Receives Pharmaceuticals Pilot Plant Contract From Novo Nordisk A/S (NVO) 9/30/2014
DanDrit Biotech A/S Signs Agreement To Commence Clinical Trials Of MelcancerVac® 9/30/2014
Glialogix And National Multiple Sclerosis Society Enter Into Collaboration To Support Development Of A New Oral Therapy For Progressive Multiple Sclerosis 9/30/2014
Horus Pharma And NovaMedica Sign Agreement To Market A Portfolio Of Eye Care Products In Russia 9/30/2014
Pfizer (PFE) And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 9/30/2014
GE Healthcare, GlaxoSmithKline (GSK) Forge Commercial Oncology Testing Pact 9/30/2014
AmerisourceBergen Corporation (ABC) Selects IBM Corporation (IBM) To Manage IT Infrastructure 9/30/2014
MIT Holding Inc. (MITD) (MITD) Partnership Commences Treatment Of Patients In Phase 3 FDA Clinical Trial With SERRG 9/30/2014
KAI Research, Inc. Awarded Centers for Disease Control and Prevention (CDC) Contract To Support Annual Influenza Vaccine Serology Testing 9/30/2014
Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA) 9/29/2014
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014
Kamada Ltd. (KMDA) Extends Glassia Agreement With Baxter International, Inc. (BAX) 9/29/2014
ADM Tronics Unlimited (ADMT) Joins Triotech Ventures Technology Consortium 9/29/2014
Merck & Co. (MRK) Partners With eSSENTIAL Accessibility To Offer App For People With Disabilities 9/29/2014
Galmed Pharmaceuticals And Itamar Medical Ltd. To Collaborate On Assessing Aramchol's Effect On Endothelial Function 9/29/2014
Sigmoid Pharma Enters Into A Licence Agreement With PendoPharm Inc. For Commercialisation Rights To CyCol® In Canada 9/29/2014
Agilent Technologies Inc. (A) To Collaborate With Agilent Technologies, Inc. (Santa Clara, California) (A) On Metabolomics MRM Library-Software Solution To Accelerate Cell Biology, Disease Research 9/29/2014
Benchworks Collaborates With Boston Therapeutics, Inc. To Market Sugardown® 9/29/2014
Yale University And Leica Microsystems Partner To Establish Microscopy Center Of Excellence 9/29/2014
Ohio Clinical Trials Collaborative Launches In European Market 9/29/2014
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative With Oregon Health & Science University (OHSU) 9/29/2014
Bay Area's Pharmacyclics, Inc. (PCYC) Stock Slumps After Ending Servier Collaboration 9/26/2014
BioMotiv Attracts $25 Million Investment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 9/26/2014
Tauriga Sciences Inc. (TAUG) Restructures Honeywood Transaction And Establishes Licensing And Supply Agreement 9/26/2014
PharmaEngine, Inc. And Merrimack Amend MM-398 License Agreement 9/26/2014
Sumitomo Dainippon Pharma, SanBio, Inc. Strike $199 Million Stroke Deal 9/26/2014
Ligand Pharmaceuticals Inc. (LGND) Earns Milestone Payment Triggered By EU Approval Of Merck & Co. (MRK)’s Captisol-Enabled NOXAFIL® (posaconazole) Concentrate For Solution For Infusion 9/26/2014
Sagent Pharmaceuticals, Inc.-Hengrui Partnership Launches Second Cancer Drug In U.S. 9/26/2014
Xybion Wins Government Contract With CDC 9/26/2014
MetaSysX, Potsdam Is Pleased To Announce The Closure Of A Service Agreement With Bayer CropScience AG 9/26/2014
Gilead Sciences, Inc. (GILD) Release: The Medicines Patent Pool Adds New Sub-Licensing Agreements To Improve Access To Novel Arvs In Developing Countries 9/25/2014
Baxter International, Inc. (BAX) Inks A $970 Million Pact For Merrimack Pharmaceuticals Inc. (MACK)'s Lead Cancer Drug MM-398 9/25/2014
Thermo Fisher Scientific (TMO) Announces Agreement With GlaxoSmithKline (GSK) And Pfizer (PFE) To Develop Oncology Companion Diagnostics Using Next-Generation Sequencing (NGS) 9/25/2014
MannKind Corporation (MNKD) Announces Closing Of Global Licensing Agreement With Sanofi (France) (SAN.PA) 9/25/2014
Ambry Genetics Partners In Hereditary Cancer Research Registry, PROMPT 9/25/2014
EPIRUS Biopharmaceuticals And Livzon Mabpharm Enter Collaboration Agreement For China 9/25/2014
PHT Corporation Logpad® System Selected By Agile Therapeutics, Inc. For Use In Its Phase 3 Trial Of Twirla® Investigational Contraceptive Patch 9/24/2014
Innovus Pharma Strikes $171.25 Million Zestra Deal With Sothema Laboratories 9/24/2014
Cortex Pharmaceuticals, Inc. (COR) Announces Phase 1 Funding By The National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) Under The Small Business Innovation Research Funding Award Program 9/24/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Expands Cancer Immunotherapy Platform With Antigen-Specific T-Cell Technology Licensed From California Institute of Technology 9/24/2014
IMRIS Announces Waiver And Amendment Agreement And Repricing Of Warrants 9/24/2014
Global Discovery Biosciences Announces Collaboration With IPMD, Inc. To Develop Innovative Aptamer-Based Blood Test For The Early Detection Of Lung Cancer 9/24/2014
AIT, BioVendor And Scienion AG Signed Cooperation Agreement For Early Detection Of Colon Cancer 9/24/2014
Genzyme Corporation (GENZ) Collaborates On Gene Therapy For Rare Disease That Causes Childhood Blindness 9/24/2014
Advanced Care Scripts To Provide Integrated Pharmacy SolutionFor SIVEXTRO™ (Tedizolid Phosphate) 9/24/2014
Probi And Pharmavite Expand Collaboration In The U.S. And International Markets 9/24/2014
TG Therapeutics, Inc. (MHA) Announces Exercise Of License Option For Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202 9/23/2014
Cancer Genetics, Inc. (CGIX) And Beth Israel Deaconess Medical Center Enter Into Collaboration To Correlate Genomic Profiles To Patient Outcome In Diffuse Large B-Cell Lymphoma 9/23/2014
Novavax, Inc. (NVAX) Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option 9/23/2014
Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan-Kettering Cancer Center 9/23/2014
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014
Tekmira Pharmaceuticals Corporation (TKMR) Joins International Consortium To Conduct Clinical Trials Of Ebola Virus Therapeutics In West Africa 9/23/2014
Renewal Of The Sanofi-GENFIT Corp. (ALGFT) Agreement 9/23/2014
Calixar And Virpath Develop An Innovative Manufacturing Process For High Performance Influenza Vaccines 9/23/2014
FORMA Therapeutics, Inc. And H. Lee Moffitt Cancer Center & Research Institute Establish Multiyear Epigenetics Alliance 9/23/2014
Kyocera Corporation (KYO) Joins Imec's Industrial Affiliation Program On Advanced Silicon Solar Cell Technology 9/23/2014
Mabion Signed An Agreement For The Realization Of A Clinical Trial Of The Drug MabionHER2 9/23/2014
Innovus Pharma, Orimed Pharma Ink $94.5 Million+ Zestra® Pact 9/22/2014
Fidia Pharma USA Inc. Partners With AEONSurgical To Expand Its US Sales Presence 9/22/2014
Generex Biotechnology Corporation (GNBT) Collaborates With University Health Network For Buccal Insulin Project 9/22/2014
SCHOTT Corporation And Algatechnologies Join R&D Forces 9/22/2014
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs 9/22/2014
CSPC Pharmaceutical Group To Support Drug Discovery Work At Columbia University 9/22/2014
Abcam plc (ABC.L) Licenses Novel Ceefourin Inhibitors Of Multidrug Resistance Protein 4 From Australia’s Children’s Cancer Institute 9/22/2014